This recommended patent litigation team continues to battle prominently for NPEs such as IPCom and Sisvel in proceedings involving mobile communications and electronics patents. But reducing the firm to litigator for NPEs would be too simplistic. The small team’s client list also features Hengeler-typical industrial clients, e.g. Samsung and AstraZeneca. The litigation practice thus currently focuses on mobile communications and pharmaceuticals patents. However, the team is barely growing, either in size or in terms of work. The fact that it is currently unable to play a key role in other major series of proceedings is partly because it is too small, with Kellenter as the only partner. That said, Hengeler did appoint a counsel in IP, so an additional partner appointment is within sight.
Dr. Wolfgang Kellenter.
1 partner, 1 counsel, 3 associates
Its small size could limit the team’s possibilities in the UPC system. It will also have to devote much attention to its European cooperation partners at the other key UPC locations. But as part of a national full-service firm, the team will struggle to enter into more exclusive partnerships.
All-round IP activity with a clear focus on patents: primarily litigation, also strategic advice, assessment of technical protection rights and transactions. Trademarks and unfair competition.
IPCom regarding GSM patents; Sisvel regarding TV patents; Samsung concerning UMTS patents; AstraZeneca regarding Seroquel.